Annette Haberl

Determinants of Virological Failure after Successful Viral Load Suppression in First-Line Highly Active Antiretroviral Therapy

Anna María Geretti, Colette Smith, Annette Haberl et al. · Antiviral Therapy · 2008 · 102 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1–Infected Women

Stein Schalkwijk, Angela Colbers, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2017 · 72 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Immune Response after Two Doses of the Novel Split Virion, Adjuvanted Pandemic H1N1 Influenza A Vaccine in HIV-1-Infected Patients

Markus Bickel, Nils von Hentig, Imke Wieters et al. · Clinical Infectious Diseases · 2010 · 70 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: Are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

Ingeborg Fraunholz, Daniela Rabeneck, Johanna Gerstein et al. · Radiotherapy and Oncology · 2010 · 65 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

Markus Bickel, Imke Wieters, Pavel Khaykin et al. · AIDS · 2010 · 65 citations

Veterinary Medicine, Immunology, Infectious Diseases +17